COLL FY 2018 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$280M+884.7% YoY

Gross Profit

$115M40.9% margin

Operating Income

-$21M-7.4% margin

Net Income

-$39M-14.0% margin

EPS (Diluted)

$-1.19

Cash Flow

Operating Cash Flow

$169M

Free Cash Flow

$145M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$291M

Total Liabilities

$200M

Stockholders' Equity

$92M

Cash & Equivalents

$147M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$280M	$28M	+884.7%
Gross Profit	$115M	$26M	+343.3%
Operating Income	-$21M	-$75M	+72.6%
Net Income	-$39M	-$75M	+47.7%